Home / Brands / Azurity Pharmaceuticals
Azurity Pharmaceuticals Recalls
4 recalls on record · October 13, 2021 to February 7, 2024 · Drugs
Recalls by year
21
23
24
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
February 7, 2024DrugsFDA
Azurity Pharmaceuticals, Inc. recalls Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals,
Hazard: Labeling: Label Mix-up
January 10, 2024DrugsFDA
Azurity Pharmaceuticals, Inc. recalls Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn
Hazard: Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.
April 12, 2023DrugsFDA
Azurity Pharmaceuticals, Inc. recalls Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, packaged in: a) 10 mL multiple-dose vials (NDC 52536-625-10) and
Hazard: cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
October 13, 2021DrugsFDA
Azurity Pharmaceuticals, Inc. recalls Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing 7.
Hazard: Product Mix-up: Incorrect diluent component included in the kit.